Filing Flows › Biogen (BIIB) › Who owns the stock
Who owns Biogen (BIIB) stock
998 funds reported Biogen (BIIB) shares in their latest 13F filings, worth $32.5B in all. The largest holder is FMR LLC ($3.9B). Last quarter 482 funds added to their stakes and 353 cut them. Members of Congress and other officials disclosed 9 trades (6 buys, 3 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| FMR LLC | 18,217,239 | $3.9B | increase | 2026-06-30 |
| BlackRock | 15,985,736 | $3.5B | increase | 2026-06-30 |
| Primecap Management | 15,154,606 | $3.3B | increase | 2026-06-30 |
| Vanguard Group | 17,447,092 | $3.1B | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 9,651,117 | $2.1B | increase | 2026-06-30 |
| State Street | 7,344,327 | $1.6B | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 6,604,936 | $1.4B | increase | 2026-06-30 |
| Geode Capital Management, LLC | 4,449,295 | $958M | increase | 2026-06-30 |
| Wellington Management Group LLP | 3,117,469 | $674M | increase | 2026-06-30 |
| Morgan Stanley | 2,411,271 | $521M | increase | 2026-06-30 |
| AQR Capital Management LLC | 1,936,859 | $417M | increase | 2026-06-30 |
| Invesco | 1,803,944 | $390M | increase | 2026-06-30 |
| Legal & General Group | 1,493,289 | $323M | increase | 2026-06-30 |
| Northern Trust | 1,429,490 | $309M | decrease | 2026-06-30 |
| Amundi | 1,316,534 | $297M | decrease | 2026-09-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-09-24 | Maria Elvira Salazar | partial sale | $1K–$15K |
| 2026-08-18 | Kevin Hern | sale | $1K–$15K |
| 2026-06-05 | Gilbert Cisneros | purchase | $1K–$15K |
| 2026-06-02 | Maria Elvira Salazar | sale | $15K–$50K |
| 2026-05-12 | Maria Elvira Salazar | purchase | $1K–$15K |
| 2026-05-11 | Maria Elvira Salazar | purchase | $1K–$15K |
| 2026-05-11 | Maria Elvira Salazar | purchase | $50K–$100K |
| 2026-03-27 | Alan Armstrong | purchase | $1K–$15K |
| 2026-01-30 | Gilbert Cisneros | purchase | $1K–$15K |
Biogen's latest quarter
Biogen, Q3 2026: revenue $2.8B (+11% year over year), operating margin -0.3%, net loss $20.6M, operating cash flow $641M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most BIIB stock?
By the latest 13F filings: FMR LLC ($3.9B); BlackRock ($3.5B); Primecap Management ($3.3B); Vanguard Group ($3.1B); Vanguard Capital Management LLC ($2.1B).
Has Congress traded BIIB stock?
Officials disclosed 9 trades on file: 6 buys and 3 sales. The latest: Maria Elvira Salazar, partial sale on 2026-09-24.
What is the short interest in BIIB?
5,500,386 shares were sold short at the 2026-10-15 settlement, -7.8% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.